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Introduction: The pathogenesis and treatment of infected wounds continues to be a challenging 
problem and represents a considerable healthcare burden. An effective treatment of wound infection 
requires combined drugs, which may reduce time to healing and minimize impact on patients, healthcare 
systems and society.
The purpose of the study was to develop the technology of preparation of a new, original, 
combined ointment containing of izohydrafural, methyluracil and benzocaine. It aims to Associate the 
antibacterial action of izohydrafural, the regenerating action of methyluracil and the local anesthetic 
action of benzocaine. The active substances have been incorporated in different pharmaceutical 
excipients to develop the optimal formula of the combined ointment. It was established that the lipophilic 
excipients are the most optimal base for the technology of the ointment.
Materials and methods: It was used the active substances: izohydrafural, methyluracil and 
benzocaine, the excipients: vaseline, oleum vaselini, cetostearyl alcohol, polyethylene glycol 400 and 
purified water.
Discussion results: It is already known the antibacterial action of the original, active substance 
izohydrafural, which is a derivative of 5-nitrofuran with valuable insights into the treatment of infected 
wounds and not only. The polyvalent nature of the infection requires a complex treatment. That’s why 
the association of izohydrafural with regenerating substances and local anesthetics in the same 
pharmaceutical form, will solve the problems related to pain and term of regenerative process, 
facilitating the treatment of infected wounds.
The active substances have been incorporated into lipophilic and hydrophilic excipients to 
develop the manufacturing technology of the combined ointment. It was investigated 12 compositions 
according to general criteria of the preformulation of ointments. The lipophilic excipients proved to be 
the most optimal, due to the lipophilic nature of benzocaine and methyluracil. Izohydrafural was 
incorporated using the water in oil emulsion base: cetostearyl alcohol. 
It was established the sequence of incorporation of the ingredients into the ointment. The 
technological process of preparation of the combined ointment contains the following steps: (1) 
Preparation of the active substances; (2) Preparation of the excipients; (3) Incorporation of the active 
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substance into the base of ointment; (4) Quality control of the combined ointment; (5) Packaging of 
finished product.
Conclusion: It was developed the technology of preparation of a new, original, combined 
ointment containing izohydrafural, methyluracil and benzocaine, which will be the basis for the 
Technological Laboratory Regulation for manufacture of investigational series of product.
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Introduction: Matricaria chamomilla L. is a well-known and a long used medicinal plant. The 
rational phytotherapy trends impose strict control of the plant material used to treat ailments. Therefore, 
the source and the quality of the raw material is highly important for obtaining a herbal medicinal product 
with certain biologic activity. Our aim was to obtain, standardize (TLC, UPLC) and biologically evaluate 
a hydro-alcoholic extract from chamomile flowers (ethanol 50 %; 2.5 g/100 mL) of known origin. 
Materials and Methods: The phytochemical analysis used thin layer chromatography (TLC) 
and liquid chromatography techniques (UPLC). Since most of the pharmacological properties of 
chamomile extracts are known, we used several in vitro (Folin –Ciocalteu assays, scavenging capacity 
against DPPH and ABTS radical) and in vivo (radial plus maze, forced swimming, Y test) tests to assess 
its potential in neurological disorders such as Parkinson and Alzheimer. The animal model was induced 
by intracerebroventricular (i.c.v.) injection of scopolamine and all surgical procedures were conducted 
under aseptic conditions with sodium pentobarbital anesthesia, to minimize animal suffering and to 
reduce the number of animal used (white, Wistar male rats, b.w 200±50g). The animal’s behavioral 
activities within pharmacological tests were statistically analyzed with two-way analysis of variance 
(ANOVA). All results are expressed as mean ± standard error of mean (S.E.M.).
Results: TLC and UPLC confirmed the presence of luteolin and apigenin glycosides, as well as 
caffeic and chlorogenic acids. Apigenin-7-glucoside amounted up to 0.42%, higher than the European 
Pharmacopoeial limit (minimum 0.25%). Total polyphenol content of the extract was 68.70 ± 2.55 mg 
GAE/g. The investigated extract had a good scavenging activity both against DPPH radical (IC50 = 47,8 
± 1,4 µg/mL) and ABTS cation (IC50 = 21,4 ± 0,2 µg/mL), comparable with the IC50 values of the 
chosen standard (caffeic acid). The scopolamine-treated rats exhibited disorientation, a decreased 
exploratory activity, a low percentage of the time spent and number of entries in the open arm within 
elevated plus-maze test and a decreased swimming time and increased immobility time within forced 
swimming test. Intraperitoneal administration of chamomile extract in doses of 25 mg/kg b.w. or 75 
mg/kg b.w. significantly induced anxiolytic- and antidepressant-like effects. Moreover, short memory 
was improved considerably as compared to the positive control group.
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